Hirudinaria granulosa, qurse mafasil
Biologicalcompare the efficacy of both groups
Other names: leech and drug
NCT Number: NCT02612974
This study has been designed to conduct as Randomized comparative clinical study.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Phase 2
Two groups, group B received Qurse Mafasil tablet orally two tablets two times daily for 8 weeks while group A received Leech therapy once weekly for 8 weeks along with Qurse mafasil.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
compare the efficacy of both groups
Other names: leech and drug
Time frame: end of 6 weeks
Time frame: end of 6 weeks
Time frame: end of 6 weeks
Time frame: end of 6 weeks
Time frame: end of 6 weeks
Time frame: end of 6 weeks
Hamdard University
Other
Randomized Controlled Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis
Acronym: Leech Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04343716
Arthritis, Chronic Pain
Birmingham, Alabama, United States
View Trial DetailsNCT06358521
Arthritis, Hip Osteoarthritis
Kingston, Ontario, Canada
View Trial DetailsNCT06272825
Arthritis, Joint Diseases
Kırşehir, City Center, Turkey (Türkiye)
View Trial DetailsNCT02598804
Arthritis, Behavior
Clermont-Ferrand, France
View Trial Details